GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LivaNova PLC (FRA:LIA) » Definitions » Cyclically Adjusted PB Ratio

LivaNova (FRA:LIA) Cyclically Adjusted PB Ratio : 1.04 (As of Apr. 29, 2025)


View and export this data going back to 2000. Start your Free Trial

What is LivaNova Cyclically Adjusted PB Ratio?

As of today (2025-04-29), LivaNova's current share price is €32.80. LivaNova's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was €31.51. LivaNova's Cyclically Adjusted PB Ratio for today is 1.04.

The historical rank and industry rank for LivaNova's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:LIA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.03   Med: 3.66   Max: 15.43
Current: 1.14

During the past years, LivaNova's highest Cyclically Adjusted PB Ratio was 15.43. The lowest was 1.03. And the median was 3.66.

FRA:LIA's Cyclically Adjusted PB Ratio is ranked better than
67.35% of 490 companies
in the Medical Devices & Instruments industry
Industry Median: 1.825 vs FRA:LIA: 1.14

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

LivaNova's adjusted book value per share data for the three months ended in Dec. 2024 was €23.199. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €31.51 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


LivaNova Cyclically Adjusted PB Ratio Historical Data

The historical data trend for LivaNova's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LivaNova Cyclically Adjusted PB Ratio Chart

LivaNova Annual Data
Trend Apr15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.02 3.56 1.96 1.68 1.41

LivaNova Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.68 1.79 1.72 1.63 1.41

Competitive Comparison of LivaNova's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, LivaNova's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LivaNova's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where LivaNova's Cyclically Adjusted PB Ratio falls into.


;
;

LivaNova Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

LivaNova's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=32.80/31.51
=1.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LivaNova's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, LivaNova's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=23.199/135.1000*135.1000
=23.199

Current CPI (Dec. 2024) = 135.1000.

LivaNova Quarterly Data

Book Value per Share CPI Adj_Book
201501 8.934 99.200 12.167
201504 9.831 99.900 13.295
201507 10.250 100.000 13.848
201510 5.079 100.300 6.841
201603 33.445 100.400 45.004
201606 33.078 101.000 44.246
201609 33.089 101.500 44.043
201612 33.692 102.200 44.538
201703 33.707 102.700 44.341
201706 34.066 103.500 44.467
201709 33.324 104.300 43.165
201712 31.767 105.000 40.874
201803 30.461 105.100 39.156
201806 31.415 105.900 40.077
201809 31.424 106.600 39.825
201812 27.420 107.100 34.589
201903 27.233 107.000 34.385
201906 27.128 107.900 33.967
201909 28.053 108.400 34.963
201912 25.707 108.500 32.009
202003 25.945 108.600 32.276
202006 24.326 108.800 30.206
202009 23.599 109.200 29.196
202012 18.740 109.400 23.142
202103 18.328 109.700 22.572
202106 17.630 111.400 21.381
202109 20.962 112.400 25.195
202112 21.511 114.700 25.337
202203 21.952 116.500 25.457
202206 22.666 120.500 25.412
202209 21.644 122.300 23.909
202212 21.282 125.300 22.947
202303 21.322 126.800 22.718
202306 21.272 129.400 22.209
202309 21.319 130.100 22.138
202312 21.729 130.500 22.495
202403 20.754 131.600 21.306
202406 21.260 133.000 21.596
202409 21.738 133.500 21.999
202412 23.199 135.100 23.199

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


LivaNova  (FRA:LIA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


LivaNova Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of LivaNova's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


LivaNova Business Description

Traded in Other Exchanges
Address
20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

LivaNova Headlines

No Headlines